Relic Technologies Ltd (511712)
Latest quarterly results (Q1 FY27)
In its latest reported quarter, Q1 FY27, Relic Technologies' revenue was ₹0.4 Cr (-72.3% year on year, -24.5% on the previous quarter), and net profit ₹-1.0 Cr (a smaller loss than a year earlier); the operating margin was -328.6%.
| Q1 FY27 (₹ Cr) | Value | YoY vs Q1 FY26 | QoQ |
|---|---|---|---|
| Revenue | ₹0.4 | -72.3% | -24.5% |
| Operating profit | ₹-1.2 | loss narrowed | loss widened |
| Net profit | ₹-1.0 | loss narrowed | loss narrowed |
| EPS (₹) | -1.16 | loss narrowed | loss narrowed |
| Operating margin | -328.6% | — | — |
📢 Recent Corporate Announcements
Relic Technologies has confirmed zero deviation in the utilization of funds raised through its preferential issue for the quarter ended June 30, 2026. The capital was raised via equity shares and warrants allotted on April 05, 2025, with warrants subsequently converted into equity on December 13, 2025. The Audit Committee reviewed the utilization on August 13, 2026, and found it consistent with the objects approved in the March 18, 2025, EGM. This routine filing confirms that the company is deploying capital as per its stated shareholder-approved mandate.
- Confirmed zero deviation in fund utilization for the quarter ended June 30, 2026
- Preferential allotment of equity shares and warrants was completed on April 05, 2025
- Share warrants were converted into equity shares on December 13, 2025
- Audit Committee reviewed and approved the statement on August 13, 2026
Relic Technologies reported a consolidated net loss of ₹1.03 Cr for Q1 FY27, an improvement from the ₹3.68 Cr loss in Q1 FY26. Consolidated revenue from operations fell sharply by 72% YoY to ₹35.49 Lakhs from ₹1.28 Cr. On a standalone basis, the company turned profitable with a net profit of ₹21.47 Lakhs, aided by ₹43 Lakhs in other income. A significant development is the commencement of a new trading vertical in pharmaceuticals and wellness products, which contributed ₹21.15 Lakhs to standalone revenue.
- Consolidated Net Loss narrowed to ₹1.03 Cr compared to a loss of ₹3.68 Cr in the same quarter last year.
- Consolidated Revenue from operations declined 72.3% YoY to ₹35.49 Lakhs.
- Standalone operations reported a Net Profit of ₹21.47 Lakhs, primarily driven by ₹43 Lakhs in Other Income.
- Commenced new trading activities in pharmaceuticals and wellness products during the quarter.
- Consolidated employee benefit expenses remain high at ₹78.79 Lakhs, exceeding total income of ₹57.86 Lakhs.
Relic Technologies reported a consolidated net loss of ₹1.03 Cr for the quarter ended June 30, 2026, showing improvement from a loss of ₹3.68 Cr in the same period last year. Consolidated revenue from operations fell significantly by 72% YoY to ₹35.49 Lakhs. On a standalone basis, the company turned a profit of ₹21.47 Lakhs, largely supported by ₹43 Lakhs in other income and the commencement of a new pharmaceutical and wellness product trading business. However, its subsidiaries (Relic Pharma and Truhealthy Wellness) remain a major drag, contributing a combined loss of ₹1.24 Cr.
- Consolidated Net Loss narrowed to ₹102.75 Lakhs from ₹368.32 Lakhs in the year-ago quarter.
- Consolidated Revenue from Operations declined to ₹35.49 Lakhs from ₹128.15 Lakhs YoY.
- Standalone Net Profit rose to ₹21.47 Lakhs, aided by ₹43 Lakhs in Other Income.
- Subsidiaries reported a combined net loss of ₹124.22 Lakhs on a small revenue base of ₹14.34 Lakhs.
- Commenced new revenue stream from trading in pharmaceuticals, nutraceuticals, and healthcare products.
Relic Technologies has scheduled a board meeting on August 13, 2026, to approve its unaudited financial results for the quarter ended June 30, 2026. The company is currently in a weak financial position with a TTM revenue of only ₹3 Cr and a substantial TTM loss of ₹7 Cr. Operating margins are deeply negative at -183.9%, and the company has seen a significant revenue decline from ₹1.28 Cr in June 2025 to ₹0.47 Cr in March 2026. Investors will be looking for any signs of operational stabilization in the upcoming results.
- Board meeting scheduled for August 13, 2026, to approve Q1 FY27 results.
- Trading window has been closed since July 01, 2026, for designated persons.
- Company reported a net loss of ₹3.68 Cr in the corresponding quarter of the previous year (June 2025).
- TTM revenue stands at a low ₹3 Cr against a market capitalization of ₹41 Cr.
- Operating profit margin (OPM) is currently at a critical -183.9%.
Relic Technologies has released its 35th Annual Report for FY 2025-26, scheduling its Annual General Meeting (AGM) for August 13, 2026. The company continues to face severe financial stress, with a TTM net loss of ₹7 Cr on a small revenue base of ₹3 Cr. Significant management changes are highlighted, including the appointment of Sachin Srivastava as CEO effective June 13, 2026, following the resignation of Karthik Iyer. The report also discloses outstanding MSME payables totaling approximately ₹14.65 lakhs including interest.
- 35th Annual General Meeting scheduled for August 13, 2026, at 12:30 p.m. via video conferencing.
- Sachin Srivastava appointed as Whole Time Director and CEO for a 3-year term starting June 13, 2026.
- Company reported a TTM net loss of ₹7 Cr, significantly exceeding its TTM revenue of ₹3 Cr.
- Outstanding dues to MSME suppliers reported at ₹13.25 lakhs principal and ₹1.40 lakhs interest.
- Promoter holding marginally increased to 44.93% in March 2026 from 44.78% in December 2025.
Financial Performance
Financial analysis data not yet available for this company.
Operational Drivers
Operational analysis data not yet available for this company.
Strategic Growth
Strategic growth analysis not yet available for this company.
External Factors
External factors analysis not yet available for this company.
Regulatory & Governance
Regulatory analysis not yet available for this company.
Risk Analysis
Risk analysis not yet available for this company.
